World Journal of Oncology


Frequency: Bimonthly
Journal Access: Open Access

ISSN-print: 1920-4531

ISSN-online: 1920-454X

Journal scope: World Journal of Oncology is an open access, peer-reviewed, international journal, publishes original contributions describing basic research and clinical investigation of cancer and neoplasms, on the cellular, molecular, prevention, diagnosis, therapy and prognosis aspects. The submissions can be basic research or clinical investigation oriented.
Indexed and covered: Chemical Abstracts (CA); Directory of Open Access Journals (DOAJ); JournalTOCs; JournalSeek; Google Scholar; PubMed and PubMed Central in processing; Elsevier EMBASE; EBSCO


Highlights

 

Most Read

 

Amplification of Genomic DNA for Decoy Receptor 3 Predicts Post-Resection Disease Recurrence in Breast Cancer Patients
Decoy receptor 3 (DcR3), a member of the tumor necrosis factor receptor (TNFR) superfamily, shows inhibitory effects on Fas-mediated apoptosis. Currently, data are lacking on the correlation between DcR3 and the recurrence of breast cancer. The authors examined DcR3 mRNA expression and genomic amplification in breast cancer, and investigated the effect of DcR3 gene amplification on prognosis of patients. A total of 95 patients formed the basis of the current retrospective study. DcR3 mRNA expression in breast cancer tissues was examined by RNase protection assay and in situ hybridization.
Read the Full Text

- Early Experiences of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Treatment in Localized Prostate Cancer

-New Considerations in the Design of Clinical Trials for Bone Metastases

-Conservative Therapy in Two Cases of Non-Hodgkin Lymphoma of the Penis: Case Reports With Review of the Literature

-Successful Retreatment With ADOC Chemotherapy in Relapsed Thymic Carcinoma: Experiences in Two Cases

-Small Cell Lung Cancer (SCLC) Presenting as Acute Pancreatitis: The Role of Hypercalcemia

-Is There a Role of Double Reporting and CT Pelvis for Lung Cancer Staging?

-Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC


Featured Article

Selective Pulmonary Artery Perfusion With Blood Flow Occlusion Delivers Concentrated Levels of Chemotherapy to Ipsilateral Hilar and Mediastinal Lymph Nodes
Although survival is historically low for patients presenting with N2 lung cancer, patients who respond to chemotherapy have up to a 30% chance for long term survival or cure. Selective pulmonary artery perfusion (SPAP) has been examined in several animal studies as a method for delivering chemotherapy in non-small cell lung cancer; however, there is a paucity of data regarding the effect of SPAP on regional lymph nodes. Full Text

Image of the Issue

Amylase-Producing Lung Cancer with a Positive Epidermal Growth Factor Receptor Mutation Treated With Gefitinib: A Case Report
A 60-year-old woman was diagnosed with metastatic pulmonary adenocarcinoma (c-stage IV) with an L858R point mutation in the gene encoding epidermal growth factor receptor (EGFR). Serum amylase levels were elevated (1,531 IU/L) with the salivary-type enzyme dominating. First-line chemotherapy using carboplatin plus paclitaxel reduced serum amylase levels, although second-line gefitinib eventually failed to control tumor growth and hyperamylasemia after 4.5 months of treatment. The cancer cells harbored a positive EGFR mutation and secreted amylase. Full Text

Current Issue

Vol. 5, No. 1, Feb 2014

Table of Contents

Original Article

Selective Pulmonary Artery Perfusion With Blood Flow Occlusion Delivers Concentrated Levels of Chemotherapy to Ipsilateral Hilar and Mediastinal Lymph Nodes Abstract HTML PDF
Preston J Sparks, Jesse Hines, Jake Lowry, Matthew Strode, Michael Roach 1-6
Age Influences Likelihood of Pancreatic Cancer Treatment, but not Outcome Abstract HTML PDF
Andrew A. Wheeler, Michael B. Nicholl 7-13
Amplification of Genomic DNA for Decoy Receptor 3 Predicts Post-Resection Disease Recurrence in Breast Cancer Patients Abstract HTML PDF
Chizuko Kanbayashi, Yu Koyama, Hiroshi Ichikawa, Eiko Sakata, Miki Hasegawa, Chie Toshikawa, Naoko Manba, Mayuko Ikarashi, Takashi Kobayashi, Masahiro Minagawa, Shin-ichi Kosugi, Toshifumi Wakai 14-23
Advanced Thyroid Cancer Patients in Phase I Clinical Trials: Outcome Assessment and Literature Review Abstract HTML PDF
Laeeq Malik, Alex Mejia 24-32

Case Report

A Case of Malignant Metastatic Pheochromocytoma After Eight Years of Primary Diagnosis Abstract HTML PDF
Sakshi Kapur, Afsheen N. Iqbal, Miles B. Levin 33-40
Amylase-Producing Lung Cancer with a Positive Epidermal Growth Factor Receptor Mutation Treated With Gefitinib: A Case Report Abstract HTML PDF
Seigo Minami, Ryu Jokoji, Suguru Yamamoto, Yoshitaka Ogata, Taro Koba, Shinji Futami, Yu Nishijima, Moto Yaga, Kentaro Masuhiro, Masahiko Tsujimoto, Kiyoshi Komuta 41-46
Alveolar Soft Part Sarcoma of the Extremity: Case Report and Literature Review Abstract HTML PDF
Khaled J. Ata, Hani N. Farsakh, Anwar Rjoop, Ismail Matalka, Liqa A. Rousan 47-51
Rectal Carcinoma Case Causing Bicytopenia Abstract HTML PDF
Sami Cifci, Aynur Ugur Bilgin, Murat Biyik, Huseyin Ataseven, Hatice Toy 52-53
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submission      |     Subscribe



World Journal of Oncology, bimonthly, ISSN 1920-4531 (print), 1920-454X (online), published by Elmer Press Inc.     

The content of this site is intended for health care professionals.
This is an open-access journal, published articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.

website: www.wjon.org   editorial contact: editor@wjon.org
Address: 9160 Boul Leduc, Bureau 410, Brossard, Quebec, J4Y 0E3, Canada

© Elmer Press Inc. All Rights Reserved.